(Q46529943)

22 December 2017

meta-analysis

0 references

title

Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials (English)

1 reference

22 December 2017

1 reference

1

1 reference

22 December 2017

Philippe Gabriel Steg

12

1 reference

22 December 2017

Marco Valgimigli

24

1 reference

22 December 2017

Alaide Chieffo

Alaide Chieffo

26

0 references

William Wijns

William Wijns

9

0 references

Marie-Claude Morice

4

Marie-Claude Morice

1 reference

22 December 2017

25

Adnan Kastrati

1 reference

22 December 2017

27

Roxana Mehran

1 reference

22 December 2017

3

Stephan Windecker

1 reference

22 December 2017

8

Patrick W Serruys

1 reference

22 December 2017

7

Gregg W Stone

1 reference

22 December 2017

David E Kandzari

14

David Kandzari

1 reference

22 December 2017

Martin B. Leon

6

Martin B Leon

1 reference

22 December 2017

Laxmi S Mehta

21

Laxmi Mehta

1 reference

22 December 2017

Pieter Smit

13

Pieter C Smits

1 reference

22 December 2017

Usman Baber

2

Usman Baber

1 reference

22 December 2017

Giora Weisz

10

Giora Weisz

1 reference

22 December 2017

Edoardo Camenzind

11

Edoardo Camenzind

1 reference

22 December 2017

Raban Jeger

17

Raban V Jeger

1 reference

22 December 2017

Samantha Sartori

5

Samantha Sartori

1 reference

22 December 2017

Clemens von Birgelen

15

Clemens Von Birgelen

1 reference

22 December 2017

Dipti Itchhaporia

20

Dipti Itchhaporia

1 reference

22 December 2017

Ghada W Mikhail

19

Ghada W Mikhail

1 reference

22 December 2017

Rebecca Ortega

22

Rebecca Ortega

1 reference

22 December 2017

author name string

Søren Galatius

16

1 reference

22 December 2017

Takeshi Kimura

18

1 reference

22 December 2017

Hyo-Soo Kim

23

1 reference

22 December 2017

language of work or name

English

0 references

publication date

2 September 2013

1 reference

22 December 2017

published in

The Lancet

1 reference

22 December 2017

volume

382

1 reference

22 December 2017

issue

9908

1 reference

22 December 2017

page(s)

1879-1888

1 reference

22 December 2017

Drug-eluting coronary-artery stents.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Drug-eluting versus bare-metal stents in large coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Comparison of zotarolimus-eluting and everolimus-eluting coronary stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Clinical end points in coronary stent trials: a case for standardized definitions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Modelling clustered survival data from multicentre clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Gender-specific outcomes after sirolimus-eluting stent implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Influence of sex on long-term outcomes after percutaneous coronary intervention with the paclitaxel-eluting coronary stent: results of the "TAXUS Woman" analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Short- and long-term outcomes of coronary stenting in women versus men: results from the National Cardiovascular Data Registry Centers for Medicare & Medicaid services cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Premarket clinical evaluation of novel cardiovascular devices: quality analysis of premarket clinical studies submitted to the Food and Drug Administration 2000-2007.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

Strategies for multivessel revascularization in patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

The problem of subgroup analyses: an example from a trial on ruptured intracranial aneurysms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2813%2961782-1

7 January 2021

10.1016/S0140-6736(13)61782-1

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

24007976

1 reference

22 December 2017